Merck
MRK
#46
Rank
A$403.27 B
Marketcap
A$163.11
Share price
0.38%
Change (1 day)
9.95%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): A$11.22

According to Merck's latest financial reports the company's current EPS (TTM) is A$10.29. an increase over its 2024 EPS that were of A$9.52.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025A$10.257.71%
2024A$9.524308.46%
2023A$0.22-97.32%
2022A$8.0710.92%
2021A$7.2784.68%
2020A$3.94-27.2%
2019A$5.4163.44%
2018A$3.31151.11%
2017A$1.32-54.58%
2016A$2.9030.21%
2015A$2.23-61.99%
2014A$5.86180.51%
2013A$2.09-31.82%
2012A$3.066.62%
2011A$2.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$15.68 52.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$10.36 0.73%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.91-81.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.28-48.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$32.41 215.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.17 96.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.91-71.74%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$4.18-59.35%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.30-48.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$1.75-83.03%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel